Showing results (371-380 of 719) with videos related to

Sort By:
Pageof 72
Preventive Medicine Reports|October 20, 2022
COVID-19 mitigation strategies: A natural experiment highlighting the importance of structure in the prevention and treatment of childhood obesityKeith Brazendale, Michael W Beets, R Glenn Weaver, et al.
The British Journal of Surgery|November 1, 1987
Effect of carotid endarterectomy on cerebral blood flow and its response to hypercapniaC C Bishop, L Butler, T Hunt, et al.
ACS Physical Chemistry Au|September 30, 2024
Understanding the Vibrational Structure and Ultrafast Dynamics of the Metal Carbonyl Precatalyst [Mn(ppy)(CO)4]Jonathan B Eastwood, Barbara Procacci, Sabina Gurung, et al.
Veterinary Microbiology|September 1, 1995
Australian-Indonesian collaboration in veterinary arbovirology--a reviewP W Daniels, I Sendow, E Soleha, et al.
Seminars in Hematology|February 4, 2003
Prognosis and prognostic factors for patients with chronic myeloid leukemia: nontransplant therapyJ Hasford, M Pfirrmann, R Hehlmann, et al.
Leukemia|October 19, 2007
Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratoriesM C Müller, P Erben, G Saglio, et al.
Investigational New Drugs|July 14, 2005
BBR 3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer: a phase II study group trial of the Central European Society of Anticancer-Drug Research (CESAR)R-D Hofheinz, C Porta, G Hartung, et al.
Onkologie|November 6, 2001
Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancerG Hartung, R D Hofheinz, A Wein, et al.
British Journal of Cancer|July 9, 2004
Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trialR-D Hofheinz, J T Hartmann, A Willer, et al.
British Journal of Haematology|April 1, 1997
Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score. German chronic myeloid leukaemia (CML)-Study GroupR Hehlmann, H Ansari, J Hasford, et al.
Pageof 72